Health Observance

World Autoimmune & Autoinflammatory Arthritis Day

ASBMB Today Staff
May 18, 2018

The International Foundation for Autoimmune & Autoinflammatory Arthritis has orchestrated an annual campaign since 2012 to raise awareness of diseases that are autoimmune in nature and that cause joint inflammation and pain. That includes such diseases as rheumatoid arthritis, lupus and Sjögren’s syndrome, to name a few. World Autoimmune/Autoinflammatory Arthritis Day is May 20 this year. The theme, with a nod to the “auto” prefix, is “Race to Fuel Awareness.” The ASBMB will observe WAAAD by sharing research and stories about the mechanisms of the diseases.

Investigating the role of AhR signaling in health and disease

In this short literature review, researchers cover what is known about how the aryl hydrocarbon receptor influences the immune response. The AhR integrates signals from food and the gut environment to modulate inflammation, making it a possible target for drugs to treat multiple sclerosis and other autoimmune diseases. Read the minireview in the Journal of Biological Chemistry.

How MHC molecules grab citrullinated peptides to foster rheumatoid arthritis

Upwards of 70 percent of rheumatoid arthritis patients test positive for antibodies that target citrullinated peptides in joint synovial fluid. Production of these antibodies depends on binding between citrullinated peptides and a particular surface receptor of antigen-presenting cells. Ting et al examined binding affinity between diverse citrullinated peptides and variants of the receptor, yielding insights into the molecular mechanisms that could be targeted to reduce the autoinflammatory response. Read an introduction to the research.Read the paper itself.

Making a better immunoglobulin

For patients with autoimmune disorders that don’t respond to traditional treatments, intravenous IG is a therapy of last resort. IVIG, however, is expensive, as the IG is derived from thousands of donors.  A synthetic IG is needed. These researchers are working on it.

The heartbreak of psoriasis

Psoriasis isn’t just an unsightly skin problem. One-third of patients with the inflammatory disease develop arthritis. On top of that, it alters HDL (“good cholesterol”) and increases the risk of heart disease. Learn more.

Understanding how an enzyme can help or harm

Variation in the enzyme endoplasmic reticulum aminopeptidase 1, or ERAP1, is associated with ankylosing spondylitis and other diseases. Some ERAP1 variants increase the risk of autoimmune disease, while others are protective. A study in the journal Molecular & Cellular Proteomics investigated how different ERAP1 variants affect antigen presentation. Here’s the paper.

Rituximab binding to target cells

The monoclonal antibody rituximab, sold as Rituxin or MabThera, is often used to treat rheumatoid arthritis. Researchers studied how carbohydrate modifications to antibody receptors can affect rituximab binding to its target cells.  They reported their findings in the journal Molecular & Cellular Proteomics. Here’s the paper. 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How opposing metabolic pathways regulate inflammation
Journal News

How opposing metabolic pathways regulate inflammation

Jan. 28, 2025

Researchers use cybernetics to understand what happens when two acids produced by macrophages compete for binding sites on the enzyme that converts them to active products.

We are all mosaics
News

We are all mosaics

Jan. 25, 2025

Your body is a collection of cells carrying thousands of genetic mistakes accrued over a lifetime — many harmless, some bad, and at least a few that may be good for you.

From the journals: MCP
Journal News

From the journals: MCP

Jan. 24, 2025

Finding biomarkers for preeclampsia. Early diagnostic biomarkers of pancreatic cancer. Better tools to identify tumor-specific peptides. Read about these recent MCP papers.

RNA binding proteins with benefits
Research Spotlight

RNA binding proteins with benefits

Jan. 22, 2025

Blanton Tolbert studies the biochemical mechanisms of RNA virus replication while working to make science more accessible, and more interesting, for all people.

A proteomic hunt for phosphosites in the aging brain
Journal News

A proteomic hunt for phosphosites in the aging brain

Jan. 21, 2025

In older mice, researchers found more enzymes that phosphorylate other proteins and changes in phosphorylation levels in proteins associated with neurodegeneration.

What if a virus could reverse antibiotic resistance?
News

What if a virus could reverse antibiotic resistance?

Jan. 19, 2025

In promising experiments, phage therapy forces bacteria into a no-win dilemma that lowers their defenses against drugs they’d evolved to withstand.